Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model

Cancer Lett. 2000 Mar 13;150(1):111-7. doi: 10.1016/s0304-3835(99)00381-x.

Abstract

The phototherapeutic properties and tissue distribution of hypericin were investigated in DBA/2 mice bearing subcutaneously transplanted P388 lymphoma cells. The efficacy of the photodynamic therapy (PDT) 2 h after administration of hypericin (2, 5, or 20 mg/kg, i.p., 120 J/cm2, 595 nm) was substantially greater than the efficacy after a 24 h interval. PDT with Photofrin (5 mg/kg, i.p., 24-h interval, 120 J/cm2, 630 nm) showed no significant antitumoral effect. The hypericin uptake in some tissues was measured after administration of hypericin (5 or 20 mg/kg, i.p.) up to 168 h. A comparison of the distribution data and the PDT efficacy at various intervals suggests that the plasma concentration of hypericin, and to a lesser extent the tumor uptake, determines the tumor response to PDT with hypericin.

MeSH terms

  • Animals
  • Anthracenes
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Injections, Intraperitoneal
  • Kidney / metabolism
  • Liver / metabolism
  • Mice
  • Mice, Inbred DBA
  • Muscles / metabolism
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / metabolism
  • Neoplasms, Experimental / surgery
  • Perylene / analogs & derivatives*
  • Perylene / blood
  • Perylene / pharmacokinetics
  • Perylene / therapeutic use
  • Photochemotherapy*
  • Radiation-Sensitizing Agents / pharmacokinetics
  • Radiation-Sensitizing Agents / therapeutic use*
  • Skin / metabolism
  • Spleen / metabolism
  • Survival Analysis
  • Time Factors
  • Tissue Distribution
  • Treatment Outcome
  • Tumor Cells, Cultured

Substances

  • Anthracenes
  • Antineoplastic Agents
  • Radiation-Sensitizing Agents
  • Perylene
  • hypericin